<DOC>
	<DOCNO>NCT03052140</DOCNO>
	<brief_summary>Single-blind , randomise , single centre , 2-way crossover study collect post-market clinical follow-up data CE-marked Lamelleye dry eye drop medical device .</brief_summary>
	<brief_title>Lamelleye v Comparator Treatment Dry Eye Disease</brief_title>
	<detailed_description>The study 2-way crossover design comprise 2 treatment : CE-marked Lamelleye dry eye drop , CE-marked comparator product . All Participants allocate treatment group random order . This study design allow observation make treatment intra- inter-patient level regard relationship patient ' disease specific quality life , symptoms adverse event .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>1 . Participant provide write informed consent . 2 . Male female Participants ≥ 18 ≤ 79 year age . 3 . Participant dry eye disease diagnose positive response Noninvasive tear breakup time ( NITBUT ) ( ≤10 second ) ; Schirmer test ( ≤10mm 5 minute ) ; patient symptom ( &gt; 2 symptom use McMonnies Dry Eye Questionnaire ) 4 . Participant must understand able , willing likely fully comply study procedure restriction . 1 . Active ocular infection 2 . Ocular surgery within 6 month study start date 3 . Current contact lens wear 4 . Any ophthalmologic drop within 1 week prior enrolment opinion CI PI may interfere study outcome . 5 . Started change dose chronic systemic medication know affect tear production include , limited antihistamine , anticholinergic , antidepressant , diuretic , corticosteroid immunomodulators within 30 day initial visit . 6 . Systemic disease know affect tear production loss include , limited thyroid eye disease , diagnose stable within 30 day Visit 1 . 7 . Known hypersensitivity agent use test allergy egg soya base product . 8 . Females wish become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>